365 related articles for article (PubMed ID: 24126138)
1. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
Zhou S; Ye W; Shao Q; Zhang M; Liang J
Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
[TBL] [Abstract][Full Text] [Related]
2. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.
Lee S; Lim MJ; Kim MH; Yu CH; Yun YS; Ahn J; Song JY
Free Radic Biol Med; 2012 Aug; 53(4):807-16. PubMed ID: 22684019
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells.
Singh B; Patwardhan RS; Jayakumar S; Sharma D; Sandur SK
J Photochem Photobiol B; 2020 Dec; 213():112080. PubMed ID: 33232882
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
Na HK; Surh YJ
Free Radic Biol Med; 2014 Feb; 67():353-65. PubMed ID: 24200599
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2.
Dong J; Li Y; Xiao H; Luo D; Zhang S; Zhu C; Jiang M; Cui M; Lu L; Fan S
Toxicol Appl Pharmacol; 2019 Feb; 364():12-21. PubMed ID: 30529626
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
Hybertson BM; Gao B; Bose SK; McCord JM
Mol Aspects Med; 2011 Aug; 32(4-6):234-46. PubMed ID: 22020111
[TBL] [Abstract][Full Text] [Related]
9. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
10. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
[TBL] [Abstract][Full Text] [Related]
11. Heat stress activates interleukin-8 and the antioxidant system via Nrf2 pathways in human dental pulp cells.
Chang SW; Lee SI; Bae WJ; Min KS; Shin ES; Oh GS; Pae HO; Kim EC
J Endod; 2009 Sep; 35(9):1222-8. PubMed ID: 19720220
[TBL] [Abstract][Full Text] [Related]
12. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention.
Giudice A; Montella M
Bioessays; 2006 Feb; 28(2):169-81. PubMed ID: 16435293
[TBL] [Abstract][Full Text] [Related]
14. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
15. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.
Singh A; Bodas M; Wakabayashi N; Bunz F; Biswal S
Antioxid Redox Signal; 2010 Dec; 13(11):1627-37. PubMed ID: 20446773
[TBL] [Abstract][Full Text] [Related]
16. Low Dose of Trichostatin A Improves Radiation Resistance by Activating Akt/Nrf2-Dependent Antioxidation Pathway in Cancer Cells.
Zhang F; Shao C; Chen Z; Li Y; Jing X; Huang Q
Radiat Res; 2021 Apr; 195(4):366-377. PubMed ID: 33513620
[TBL] [Abstract][Full Text] [Related]
17. Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis.
Hiramoto K; Satoh H; Suzuki T; Moriguchi T; Pi J; Shimosegawa T; Yamamoto M
Cancer Prev Res (Phila); 2014 Aug; 7(8):835-44. PubMed ID: 24866179
[TBL] [Abstract][Full Text] [Related]
18. [Nrf2 as a chemoprevention target in gastrointestinal carcinoma].
Gao P; Tang XW; Wang XJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):453-63. PubMed ID: 22927084
[TBL] [Abstract][Full Text] [Related]
19. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
Yang JJ; Tao H; Huang C; Li J
Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
[TBL] [Abstract][Full Text] [Related]
20. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]